CVSICVSI
I think this Stock will pump so hard will melt faces
I'm buying now and around 0.10
Kindly dollar cost your investment
Good luck
0.0208USD
3.10 MUSD
16.00 MUSD
163.20 M
About CV Sciences, Inc.
Sector
CEO
Joseph D. Dowling
Headquarters
San Diego
Website
Employees (FY)
43
Founded
2010
ISIN
US1266541028
FIGI
BBG0022J68R8
CV Sciences, Inc. engages in the development, manufacture, and sale of consumer and pharmaceutical products. It operates through the following segments: Consumer Products and Specialty Pharmaceutical. The Consumer Products segment includes manufacturing, marketing, and selling of hemp-based cannabidiol products through the PlusCBD brand. The Specialty Pharmaceutical segment focuses on developing cannabinoids to treat medical indications. The company was founded by H. J. Cole, Michael J. Mona, Jr. and Michael J. Mona III on December 9, 2010 and is headquartered in San Diego, CA.
CV Science can make you highCVSI seems to have bottomed out and offers a good risk/reward ratio.
CV Science is a Cannabidiol (CBD) producer and its product is the #1 selling natural hemp extract in the USA.
Keep in mind that this is an OTC stock.
$CVSI CV Sciences, Inc. 30% Upside CV Sciences, Inc. engages in the development, manufacture, and sale of consumer and pharmaceutical products. It operates through the Consumer Products and Specialty Pharmaceutical segments. The Consumer Products segment includes manufacturing, marketing, and selling of hemp-based cannabidiol product
$CVSI Flashing Signs of Potential Bottom?CVSI had a brutal last year, but is fighting for fresh support and just broke the longstanding bear trendline suggesting that a turnaround could be in the cards.
-----------------------------
CV Sciences Inc (OTCMKTS:CVSI)
CV Sciences bills itself as a company that operates two distinct business
CV Sciences, Inc On watchlist for reversal opportunity CV Sciences, Inc. engages in the development, manufacture, and sale of consumer and pharmaceutical products. It operates through the Consumer Products and Specialty Pharmaceutical segments. The Consumer Products segment includes manufacturing, marketing, and selling of hemp-based cannabidiol product
CV Science a good risk reward tradeEntry level $2.50 with stop loss $2.15 = Profit target $4.00
Average Analysts recommendation = buy with a $6.33 price target.
CV Sciences, Inc. engages in the development, manufacture, and sale of consumer and pharmaceutical products. It operates through the Consumer Products and Specialty Pharma
$CVSI Forming A V Bottom$CVSI has been beaten up along with the rest of the cannabis sector.
Recent price action indicates that the low might be in as the critical $1.55 support level held.
Next major resistance level is $3. Those that want to go Long can buy with a stop below $1.55 and add to the position on a break abo
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CVSI is 0.0368 USD — it has decreased by 4.73% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange CV Sciences, Inc. stocks are traded under the ticker CVSI.
CV Sciences, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
CVSI stock is 14.27% volatile and has beta coefficient of −0.05. Check out the list of the most volatile stocks — is CV Sciences, Inc. there?
CVSI earnings for the last quarter are −0.01 USD whereas the estimation was −0.01 USD which accounts for 0% surprise. Estimated earnings for the next quarter are −0.01 USD. See more details about CV Sciences, Inc. earnings.
CV Sciences, Inc. revenue for the last quarter amounts to 3.97 M USD despite the estimated figure of 4.26 M USD. In the next quarter revenue is expected to reach 4.31 M USD.
Yes, you can track CV Sciences, Inc. financials in yearly and quarterly reports right on TradingView.
CVSI stock has fallen by 2.07% compared to the previous week, the month change is a 5.50% rise, over the last year CV Sciences, Inc. has showed a 24.70% decrease.
CVSI net income for the last quarter is −869.00 K USD, while the quarter before that showed −447.00 K USD of net income which accounts for −94.41% change. Track more CV Sciences, Inc. financial stats to get the full picture.
Today CV Sciences, Inc. has the market capitalization of 6.01 M, it has decreased by 1.20% over the last week.
No, CVSI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CVSI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CV Sciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 43.00 employees. See our rating of the largest employees — is CV Sciences, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CV Sciences, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CV Sciences, Inc. stock shows the sell signal. See more of CV Sciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CV Sciences, Inc. EBITDA is −2.17 M USD, and current EBITDA margin is −13.90%. See more stats in CV Sciences, Inc. financial statements.